Showing results (911-920 of 3,103) with videos related to

Sort By:
Pageof 311
Drug Safety|April 20, 2010
Development safety update reports and proposals for effective and efficient risk communicationHisashi Urushihara, Koji Kawakami
Drug Safety|April 20, 2010
Safety profile of the fluoroquinolones: focus on levofloxacinHans H Liu
Drug Safety|April 20, 2010
Modelling the time to onset of adverse reactions with parametric survival distributions: a potential approach to signal detection and evaluationFrançois Maignen, Manfred Hauben, Panos Tsintis
Drug Safety|November 1, 1990
IgE-mediated drug fever due to histamine H2-receptor blockersA Hiraide, T Yoshioka, S Ohshima
Drug Safety|October 9, 2009
Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in SpainGabriel Sanfélix-Gimeno, Pedro Cervera-Casino, Salvador Peiró, et al.
Drug Safety|June 18, 2009
Risk of fractures with glitazones: a critical review of the evidence to dateMichael Bodmer, Christian Meier, Marius E Kraenzlin, et al.
Drug Safety|June 18, 2009
Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptationChantal Schlatter, Sabin S Egger, Lydia Tchambaz, et al.
Drug Safety|June 18, 2009
Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System DatabaseCatherine Do, Eric Huyghe, Maryse Lapeyre-Mestre, et al.
Drug Safety|June 18, 2009
Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphologyClaus Graff, Mads P Andersen, Joel Q Xue, et al.
Drug Safety|May 8, 2009
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classesFrançoise Van Bambeke, Paul M Tulkens
Pageof 311